BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29236977)

  • 1. gene2drug: a computational tool for pathway-based rational drug repositioning.
    Napolitano F; Carrella D; Mandriani B; Pisonero-Vaquero S; Sirci F; Medina DL; Brunetti-Pierri N; di Bernardo D
    Bioinformatics; 2018 May; 34(9):1498-1505. PubMed ID: 29236977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
    Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
    Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ksRepo: a generalized platform for computational drug repositioning.
    Brown AS; Kong SW; Kohane IS; Patel CJ
    BMC Bioinformatics; 2016 Feb; 17():78. PubMed ID: 26860211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging Big Data to Transform Drug Discovery.
    Glicksberg BS; Li L; Chen R; Dudley J; Chen B
    Methods Mol Biol; 2019; 1939():91-118. PubMed ID: 30848458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
    Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
    Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding.
    Chen H; Cheng F; Li J
    PLoS Comput Biol; 2020 Jul; 16(7):e1008040. PubMed ID: 32667925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repositioning by integrating target information through a heterogeneous network model.
    Wang W; Yang S; Zhang X; Li J
    Bioinformatics; 2014 Oct; 30(20):2923-30. PubMed ID: 24974205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
    Sahu NU; Kharkar PS
    Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gep2pep: a Bioconductor package for the creation and analysis of pathway-based expression profiles.
    Napolitano F; Carrella D; Gao X; di Bernardo D
    Bioinformatics; 2019 Oct; 36(6):1944-5. PubMed ID: 31647521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-source chemogenomic data-driven algorithms for predicting drug-target interactions.
    Hao M; Bryant SH; Wang Y
    Brief Bioinform; 2019 Jul; 20(4):1465-1474. PubMed ID: 29420684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. deepDR: a network-based deep learning approach to in silico drug repositioning.
    Zeng X; Zhu S; Liu X; Zhou Y; Nussinov R; Cheng F
    Bioinformatics; 2019 Dec; 35(24):5191-5198. PubMed ID: 31116390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
    Nagaraj AB; Wang QQ; Joseph P; Zheng C; Chen Y; Kovalenko O; Singh S; Armstrong A; Resnick K; Zanotti K; Waggoner S; Xu R; DiFeo A
    Oncogene; 2018 Jan; 37(3):403-414. PubMed ID: 28967908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures.
    Namba S; Iwata M; Yamanishi Y
    Bioinformatics; 2022 Jun; 38(Suppl 1):i68-i76. PubMed ID: 35758779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
    Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
    Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm.
    Luo H; Wang J; Li M; Luo J; Peng X; Wu FX; Pan Y
    Bioinformatics; 2016 Sep; 32(17):2664-71. PubMed ID: 27153662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendation Techniques for Drug-Target Interaction Prediction and Drug Repositioning.
    Alaimo S; Giugno R; Pulvirenti A
    Methods Mol Biol; 2016; 1415():441-62. PubMed ID: 27115647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug-target interactions.
    Wan F; Hong L; Xiao A; Jiang T; Zeng J
    Bioinformatics; 2019 Jan; 35(1):104-111. PubMed ID: 30561548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.